Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Keywords: عامل ایمن سازی; Peripheral T-cell lymphoma; Histone deacetylase inhibitor; Antifolate; Nucleoside analog; Fusion protein; Immunomodulatory agent;